Monday, April 11, 2016

AbbVie/Roche drug gets U.S. approval for a rare type of leukemia

WASHINGTON, April 11 (Reuters) - AbbVie Inc won

U.S. regulatory approval on Monday for a new drug to treat

patients with a rare type of chronic lymphocytic leukemia, a

blood cancer.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)